Choline in acute coronary syndrome: An emerging biomarker with implications for the integrated assessment of plaque vulnerability

Expert Review of Molecular Diagnostics

Volumn 10, Issue 2, 2010, Pages 159-171

  Danne, Oliver ^a   Möckel, Martin ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Acute coronary syndrome; Chest pain; Choline; Integrated biomarker; Myocardial ischemia; Plaque imaging; Prognosis; Troponins; Vulnerable plaque

Indexed keywords

BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; CHOLINE; TROPONIN;

ACUTE CORONARY SYNDROME; ATHEROSCLEROTIC PLAQUE; DECISION MAKING; DISEASE MARKER; EMERGENCY WARD; HEART INFARCTION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; PREDICTOR VARIABLE; PROTEIN BLOOD LEVEL; REVIEW; RISK ASSESSMENT;

ACUTE CORONARY SYNDROME; BIOLOGICAL MARKERS; CHOLINE; HUMANS;

EID: 77949451445     PISSN: 14737159     EISSN: 17448352     Source Type: Journal    
DOI: 10.1586/erm.10.2     Document Type: Review

References (68)

1. Apple FS, Wu AH, Mair J et al.. Committee on Standardization of Markers of Cardiac Damage of the IFCC. Future biomarkers for detection of ischemia and risk stratification in acute coronary syndrome. Clin. Chem. 51, 810-824 (2005).
2. Reichlin T, Hochholzer W, Bassetti S et al.. Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N. Engl. J. Med. 361(9), 858-867 (2009).
3. Wu AH, Jaffe AS. The clinical need for high-sensitivity cardiac troponin assays for acute coronary syndromes and the role for serial testing. Am. Heart J. 155(2), 208-214 (2008).
4. Anderson JL, Adams CD, Antman EM et al.. American College of Cardiology; American Heart Association Task Force on practice guidelines ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines. J. Am. Coll. Cardiol. 50(7), e1-e157 (2007).
5. Morrow DA, Cannon CP, Jesse RL et al.. National Academy of Clinical Biochemistry. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: clinical characteristics and utilization of biochemical markers in acute coronary syndromes. Clin. Chem. 53(4), 552-574 (2007).
6. Dolci A, Panteghini M. The exciting story of cardiac biomarkers: from retrospective detection to gold diagnostic standard for acute myocardial infarction and more. Clin. Chim. Acta 369(2), 179-187 (2006).
7. LeLeiko RM, Vaccari CS, Sola S et al.. Usefulness of elevations in serum choline and free f(2)-isoprostane to predict 30-day cardiovascular outcomes in patients with acute coronary syndrome. Am. J. Cardiol. 104(5), 638-643 (2009).
8. Body R, Griffith CA, Keevil B et al.. Choline for diagnosis and prognostication of acute coronary syndromes in the emergency department. Clin. Chim. Acta 404(2), 89-94 (2009).
9. Danne O, Möckel M, Lueders C et al.. Prognostic implications of elevated whole blood choline levels in acute coronary syndromes. Am. J. Cardiol. 91, 1060-1067 (2003).
10. Lombardini JB, Cooper MW. Elevated blood taurine levels in acute and evolving myocardial infarction. J. Lab. Clin. Med. 98, 849-859 (1981).
11. Zeisel SH, Blusztajn JK. Choline and human nutrition. Annu. Rev. Nutr. 14, 269-296 (1994).
12. Roivainen A, Forsback S, Gronroos T et al.. Blood metabolism of [methyl-11C] choline; implications for in vivo imaging with positron emission tomography. Eur. J. Nucl. Med. 27(1), 25-32 (2000).
13. Acara M, Roch-Ramel F, Rennick B. Bidirectional renal tubular transport of free choline: a micropuncture study. Am. J. Physiol. 236(2), F112-F118 (1979).
14. Martin K. Active transport of choline into human erythrocytes. J. Physiol. 191(2), 105P-106P (1967).
15. Martin K. Concentrative accumulation of choline by human erythrocytes. J. Gen. Physiol. 51(4), 497-516 (1968).
16. Deves R, Krupka RM. The comparative specificity of the inner and outer substrate transfer sites in the choline carrier of human erythrocytes. J. Membr. Biol. 80(1), 71-80 (1984).
17. Lips KS, Pfeil U, Reiners K et al.. Expression of the high-affinity choline transporter CHT1 in rat and human arteries. J. Histochem. Cytochem. 51(12), 1645-1654 (2003).
18. Vorland M, Thorsen VA, Holmsen H. Phospholipase D in platelets and other cells. Platelets 19(8), 582-594 (2008).
19. Spector AA. Plaque rupture, lysophosphatidic acid, and thrombosis. Circulation 108(6), 641-643 (2003).
20. Rother E, Brandl R, Baker DL et al.. Subtype-selective antagonists of lysophosphatidic acid receptors inhibit platelet activation triggered by the lipid core of atherosclerotic plaques. Circulation 108, 741-747 (2003).
21. Wu M, Lu Y, Chen R, Zhou H. Changes in phospholipase D activity of leukocytes during human systemic inflammatory response syndrome induced by cardiopulmonary bypass. Chin. Med. J. (Engl.) 116(6), 873-877 (2003).
22. Chiang TM. Activation of phospholipase D in human platelets by collagen and thrombin and its relationship to platelet aggregation. Biochim. Biophys. Acta 1224, 147-155 (1994).
23. Martinson EA, Scheible S, Marx-Grunwitz A, Presek P. Secreted ADP plays a central role in thrombin-induced phospholipase D activation in human platelets. Thromb. Haemost. 80, 976-981 (1998).
24. Rubin R. Phosphatidylethanol formation in human platelets: evidence for thrombininduced activation of phospholipase D. Biochem. Biophys. Res. Commun. 156, 1090-1096 (1988).
25. Haslam RJ, Coorssen JR. Evidence that activation of phospholipase D can mediate secretion from permeabilized platelets. Adv. Exp. Med. Biol. 344, 149-164 (1993).
26. Danne O, Lueders C, Storm C, Frei U, Möckel M. Whole-blood hypercholinemia and coronary instability and thrombosis. Clin. Chem. 51, 1315-1317 (2005).
27. Willinger BT, Ho WT, Exton JH. Phospholipase D mediates matrix metalloproteinase-9 secretion in phorbol ester-stimulated human fibrosarcoma cells. J. Biol. Chem. 274, 735-738 (1999).
28. O'Brien KD, Pineda C, Chiu WS, Bowen R, Deeg MA. Glycosylphosphatidylinositolspecific phospholipase D is expressed by macrophages in human atherosclerosis and colocalizes with oxidation epitopes. Circulation 99, 2876-2882 (1999).
29. Smyth SS, Hillery CA, Parise LV. Fibrinogen binding to purified platelet glycoprotein IIb-IIIa (integrin a IIb b 3) is modulated by lipids. J. Biol. Chem. 267, 15568-15577 (1992).
30. Konstantinova SV, Tell GS, Vollset SE, Nygård O, Bleie Ø, Ueland PM. Divergent associations of plasma choline and betaine with components of metabolic syndrome in middle age and elderly men and women. J. Nutr. 138(5), 914-920 (2008).
31. Brühl A, Hafner G, Loffelholz K. Release of choline in the isolated heart, an indicator of ischemic phospholipid degradation and its protection by ischemic preconditioning: no evidence for a role of phospholipase D. Life Sci. 75, 1609-1620 (2004).
32. Korth U, Krieter H, Denz C et al.. Intestinal ischaemia during cardiac arrest and resuscitation: comparative analysis of extracellular metabolites by microdialysis. Resuscitation 58(2), 209-217 (2003).
33. Griffith CA, Owen LJ, Body R, McDowell G, Keevil BG. Development of a method to measure plasma and whole blood choline by liquid chromatography tandem mass spectrometry. Ann. Clin. Biochem. 47(Pt 1), 56-61 (2010).
34. McEntyre CJ, Slow S, Lever M. Measurement of plasma free choline by high performance liquid chromatography with fluorescence detection following derivatization with 1-naphthyl isocyanate. Anal. Chim. Acta 644(1-2), 90-94 (2009).
35. Wang FL, Haubrich DR. A simple, sensitive, and specific assay for free choline in plasma. Anal. Biochem. 63, 195-201 (1975).
36. Adamczyk M, Brashear RJ, Mattingly PG, Tsatsos PH. Homogeneous chemiluminescent assays for free choline in human plasma and whole blood. Anal. Chim. Acta 579, 61-67 (2006).
37. Adamczyk M, Brashear RJ, Mattingly PG. Rapid high-throughput detection of peroxide with an acridinium-9-carboxamide: a homogeneous chemiluminescent assay for plasma choline. Bioorg. Med. Chem. Lett. 16, 2407-2410 (2006).
38. Yue B, Pattison E, Roberts WL et al.. Choline in whole blood and plasma: sample preparation and stability. Clin. Chem. 54(3), 590-593 (2008).
39. Holm PI, Ueland PM, Kvalheim G, Lien EA. Determination of choline, betaine, and dimethylglycine in plasma by a highthroughput method based on normal-phase chromatography-tandem mass spectrometry. Clin. Chem. 49(2), 286-294 (2003).
40. Ulus IH, Ozyurt G, Korfali E. Decreased serum choline concentrations in humans after surgery, childbirth, and traumatic head injury. Neurochem. Res. 23(5), 727-732 (1998).
41. Ilcol YO, Uncu G, Goren S, Sayan E, Ulus IH. Declines in serum free and bound choline concentrations in humans after three different types of major surgery. Clin. Chem. Lab. Med. 42(12), 1390-1395 (2004).
42. Buchman AL, Ament ME, Sohel M et al.. Choline deficiency causes reversible hepatic abnormalities in patients receiving parenteral nutrition: proof of a human choline requirement: a placebo-controlled trial. J. Parenter. Enteral. Nutr. 25(5), 260-268 (2001).
43. Ilcol YO, Dilek K, Yurtkuran M, Ulus IH. Changes of plasma free choline and choline-containing compounds' concentrations and choline loss during hemodialysis in ESRD patients. Clin. Biochem. 35(3), 233-239 (2002).
44. Riley SP, Talbot NJ, Ahmed MJ, Jouhal K, Hendry BM. Characterization of human erythrocyte choline transport in chronic renal failure. Nephrol. Dial. Transplant. 12(9), 1921-1927 (1997).
45. Rennick B, Acara M, Hysert P, Mookerjee B. Choline loss during hemodialysis: homeostatic control of plasma choline concentrations. Kidney Int. 10(4), 329-335 (1976).
46. Acara M, Rennick B, LaGraff S, Schroeder ET. Effect of renal transplantation on the levels of choline in the plasma of uremic humans. Nephron 35(4), 241-243 (1983).
47. Friesen RW, Novak EM, Hasman D, Innis SM. Relationship of dimethylglycine, choline, and betaine with oxoproline in plasma of pregnant women and their newborn infants. J. Nutr. 137(12), 2641-2646 (2007).
48. Ozarda Ilçöl Y, Ozyurt G, Kilicturgay S, Uncu G, Ulus IH. The decline in serum choline concentration in humans during and after surgery is associated with the elevation of cortisol, adrenocorticotropic hormone, prolactin and b-endorphin concentrations. Neurosci. Lett. 324(1), 41-44 (2002).
49. Zeisel SH. Choline: an essential nutrient for humans. Nutrition 16(7-8), 669-671 (2000).
50. Zeisel SH. Gene response elements, genetic polymorphisms and epigenetics influence the human dietary requirement for choline. IUBMB Life 59(6), 380-387 (2007).
51. Bidulescu A, Chambless LE, Siega-Riz AM, Zeisel SH, Heiss G. Usual choline and betaine dietary intake and incident coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) study. BMC Cardiovasc. Disord. 7, 20 (2007).
52. Möckel M, Danne O, Müller R et al.. Development of an optimized multimarker strategy for early risk assessment of patients with acute coronary syndromes. Clin. Chim. Acta 393, 103-109 (2008).
53. Danne O, Lueders C, Storm C, Frei U, Möckel M. Whole blood choline and plasma choline in acute coronary syndromes: prognostic and pathophysiological implications. Clin. Chim. Acta 383, 103-109 (2007).
54. Cavusoglu E, Chhabra S, Jiang XC et al.. Relation of baseline plasma phospholipid levels to cardiovascular outcomes at two years in men with acute coronary syndrome referred for coronary angiography. Am. J. Cardiol. 100(12), 1739-1743 (2007).
55. Miles RR, Roberts RF, Putnam AR, Roberts WL. Comparison of serum and heparinized plasma samples for measurement of chemistry analytes. Clin. Chem. 50, 1704-1706 (2004).
56. Collinson PO. We don't need another hero - is there a role for ischemia biomarkers in patients with chest pain? Clin. Chim. Acta 404(2), 87-88 (2009).
57. Mizuno K, Satomura K, Miyamoto A et al.. Angioscopic evaluation of coronary-artery thrombi in acute coronary syndromes. N. Engl. J. Med. 326(5), 287-291 (1992).
58. Jaffe AS. Key issues in the developing synergism between cardiovascular imaging and biomarkers. Clin. Chem. 54(9), 1432-1442 (2008).
59. Williams G, Kolodny GM. Retrospective study of coronary uptake of 18F-fluorodeoxyglucose in association with calcification and coronary artery disease: a preliminary study. Nucl. Med. Commun. 30(4), 287-291 (2009).
60. Matter CM, Wyss MT, Meier P et al.. 18F-choline images murine atherosclerotic plaques ex vivo. Arterioscler. Thromb. Vasc. Biol. 26(3), 584-589 (2006).
61. Bucerius J, Schmaljohann J, Böhm I et al.. Feasibility of 18F-fluoromethylcholine PET/CT for imaging of vessel wall alterations in humans - first results. Eur. J. Nucl. Med. Mol. Imaging 35(4), 815-820 (2008).
62. Kato K, Schober O, Ikeda M et al.. Evaluation and comparison of 11C-choline uptake and calcification in aortic and common carotid arterial walls with combined PET/CT. Eur. J. Nucl. Med. Mol. Imaging 36(10), 1622-1628 (2009).
63. Morrow DA, de Lemos JA. Benchmarks for the assessment of novel cardiovascular biomarkers. Circulation 115(8), 949-952 (2007).
64. Morrow DA. Clinical application of sensitive troponin assays. N. Engl. J. Med. 361(9), 913-915 (2009).
65. Peacock WF. Will SCUBE1 solve the ischemia marker deficit? J. Am. Coll. Cardiol. 51(22), 2181-2183 (2008).
66. Peacock F, Morris DL, Anwaruddin S et al.. Meta-analysis of ischemia-modified albumin to rule out acute coronary syndromes in the emergency department. Am. Heart J. 152(2), 253-262 (2006).
67. Reichlin T, Hochholzer W, Stelzig C et al.. Incremental value of copeptin for rapid rule out of acute myocardial infarction. J. Am. Coll. Cardiol. 54(1), 60-68 (2009).
68. Storm C, Danne O, Lueders C, Frei U, Möckel M. Effect of the glycoprotein IIb/IIIa inhibitor tirofiban on concentrations of whole blood choline in acute coronary syndromes. LabMedicine 39, 349-355 (2008).